Application 200875
- Type
- ANDA
- Sponsor
- TEVA PARENTERAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | SOLUTION;INHALATION | EQ 0.25% BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-4147 | Levalbuterol | Levalbuterol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-4147 | Levalbuterol | Levalbuterol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-4147 | Levalbuterol | Levalbuterol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |